Technology
Health
Biotechnology

iBio

$0.8995
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0005 (-0.06%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell iBio and other stocks, options, ETFs, and crypto commission-free!

About

iBio, Inc., also called iBio, is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. Read More It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.

Employees
8
Headquarters
New York, New York
Founded
1993
Market Cap
16.95M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
134.65K
High Today
$0.903
Low Today
$0.8752
Open Price
$0.903
Volume
27.89K
52 Week High
$2.60
52 Week Low
$0.495

Collections

Technology
Health
Biotechnology
US
North America

News

Simply Wall StFeb 28

Here’s What We Think About iBio, Inc.’s (NYSEMKT:IBIO) CEO Pay

In 2008 Robert Kay was appointed CEO of iBio, Inc. (NYSEMKT:IBIO). First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will consider the growth in the business. And finally we will reflect on how common stockholders have fared in the last few years, as a secondary measure of performance. This method should give us information to assess how appropriately the company pays the CEO. Check out our latest analysis for iBio How Does Robert Kay’s Compensa...

128
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.